Geoff Mcdonough - Oct 15, 2024 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
Stock symbol
GBIO
Transactions as of
Oct 15, 2024
Transactions value $
-$3,746
Form type
4
Date filed
10/17/2024, 04:05 PM
Previous filing
Jul 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBIO Common Stock Options Exercise +5.27K +0.4% 1.34M Oct 15, 2024 Direct F1
transaction GBIO Common Stock Tax liability -$3.75K -1.55K -0.12% $2.42 1.34M Oct 15, 2024 Direct
holding GBIO Common Stock 226K Oct 15, 2024 By 2018 Trust F2
holding GBIO Common Stock 275K Oct 15, 2024 By 2020 Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBIO Restricted Stock Units Options Exercise $0 -5.27K -10% $0.00 47.5K Oct 15, 2024 Common Stock 5.27K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of the company's common stock.
F2 The securities are directly held by the McDonough Family 2018 Irrevocable Trust, or the 2018 Trust. The reporting person is the settlor of the 2018 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2018 Trust, and the 2018 Trust is for the benefit of Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2018 Trust.
F3 The securities are directly held by the McDonough Family 2020 Irrevocable Trust, or the 2020 Trust. The reporting person is the settlor of the 2020 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2020 Trust, and the 2020 Trust is for the benefit of Allison, Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2020 Trust.
F4 On January 20, 2023, the reporting person was granted 84,375 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.